Integrity Laboratories
Integrity Laboratories is a leading biotechnology firm committed to antimicrobial stewardship through high-complexity clinical diagnostics. They focus on rapid, precise diagnostic testing to improve healthcare outcomes, support healthcare systems, and combat infectious diseases including COVID-19. Their mission emphasizes honesty, transparency, and integrity in serving their clients and patients.
Industries
Nr. of Employees
small (1-50)
Integrity Laboratories
Knoxville, Tennessee, United States
Products
Multiplex respiratory molecular assay (SARS‑CoV‑2, influenza A/B, RSV)
A multiplex single-specimen molecular assay that detects and differentiates SARS‑CoV‑2, influenza A and B, and respiratory syncytial virus from the same sample.
Polymicrobial wound and biofilm molecular panel
Molecular panel for detection of multiple wound and biofilm-associated pathogens (including fungal pathogens) with quantitative reporting to support treatment decisions.
qPCR-based pathogen-load reporting
Quantitative reporting product that presents relative pathogen abundance in samples to help prioritize therapeutic targets.
Antimicrobial-resistance gene panel (molecular)
Panel detecting multiple antibiotic-resistance genes to support selection of narrow-spectrum antimicrobials.
SARS-CoV-2-RT-PCR Assay for Active Infection
A real-time RT-PCR laboratory developed test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasal, nasopharyngeal, and oropharyngeal swab specimens from individuals suspected of COVID-19.
OncoPro Dx
Precisely detects 192 clinically relevant variants across 10 oncogenes for comprehensive profiling of lung NSCLC cancer in FFPE tissue.
Multiplex respiratory molecular assay (SARS‑CoV‑2, influenza A/B, RSV)
A multiplex single-specimen molecular assay that detects and differentiates SARS‑CoV‑2, influenza A and B, and respiratory syncytial virus from the same sample.
Polymicrobial wound and biofilm molecular panel
Molecular panel for detection of multiple wound and biofilm-associated pathogens (including fungal pathogens) with quantitative reporting to support treatment decisions.
qPCR-based pathogen-load reporting
Quantitative reporting product that presents relative pathogen abundance in samples to help prioritize therapeutic targets.
Antimicrobial-resistance gene panel (molecular)
Panel detecting multiple antibiotic-resistance genes to support selection of narrow-spectrum antimicrobials.
SARS-CoV-2-RT-PCR Assay for Active Infection
A real-time RT-PCR laboratory developed test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasal, nasopharyngeal, and oropharyngeal swab specimens from individuals suspected of COVID-19.
OncoPro Dx
Precisely detects 192 clinically relevant variants across 10 oncogenes for comprehensive profiling of lung NSCLC cancer in FFPE tissue.
Services
High-complexity molecular testing services for infectious diseases, including single-pathogen and multiplex panels delivered with expedited turnaround.
Provider-facing portals and analytics to deliver actionable diagnostic data and monitor antibiotic-prescribing patterns and population trends.
In-house incubator services to accelerate diagnostic concepts to clinical/commercial readiness and support collaborative innovation projects.
High-complexity molecular testing services for infectious diseases, including single-pathogen and multiplex panels delivered with expedited turnaround.
Provider-facing portals and analytics to deliver actionable diagnostic data and monitor antibiotic-prescribing patterns and population trends.
In-house incubator services to accelerate diagnostic concepts to clinical/commercial readiness and support collaborative innovation projects.
Expertise Areas
- Molecular diagnostics (PCR-based testing)
- Infectious disease testing and surveillance
- Polymicrobial and specialized panel testing
- Antimicrobial-resistance detection and stewardship support
Key Technologies
- Real-time quantitative PCR (qRT-PCR)
- Multiplex PCR assays
- qPCR-based pathogen load quantification
- Antimicrobial-resistance gene panels (PCR-based)
News & Updates
An article discussing the superiority of Integrity Laboratories' Pathogen Load Indicator™ in PCR testing.
An article explaining the differences between COVID variants of interest and concern.
An article comparing rapid antigen tests and RT-PCR tests for COVID-19.
A report on the transmission of drug-resistant Candida auris and Integrity Laboratories' diagnostic capabilities.
An article emphasizing the importance of collaboration and understanding between laboratory technicians and physicians.
A discussion on the importance of innovation and advanced diagnostics in infectious disease management.
An article discussing the superiority of Integrity Laboratories' Pathogen Load Indicator™ in PCR testing.
An article explaining the differences between COVID variants of interest and concern.
An article comparing rapid antigen tests and RT-PCR tests for COVID-19.
A report on the transmission of drug-resistant Candida auris and Integrity Laboratories' diagnostic capabilities.
An article emphasizing the importance of collaboration and understanding between laboratory technicians and physicians.
A discussion on the importance of innovation and advanced diagnostics in infectious disease management.